Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Ulcer
Description
A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue. MeSH
Hierarchy View
Phase 3 Indicated Drugs (22)
Phase 2 Indicated Drugs (19)
Phase 1 Indicated Drugs (5)
Other Experimental Indicated Drugs (12)
Organization Involved with Phase 4 Indications (135)
All India Institute of Medical Sciences
Amrita Institute of Medical Sciences
Associated Foot & Ankle Specialists
Centro Hospitalar Lisboa Ocidental
Chinese University of Hong Kong
European Crohn´s and Colitis Organisation
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives (GETAID)
Hospital Geral de Santo António
Hospital Provincial de Castellon
Hospital Universitario Arnau de Vilanova de Lleida
Huazhong University of Science and Technology
Institute of Post Graduate Medical Education & Research
Integra LifeSciences Corporation
Istituto Clinico Humanitas - Rozzano (MI), Italy
Jawaharlal Nehru Medical College
Kliniken im Naturpark Altmuehltal
Korean College of Helicobacter and Upper Gastrointestinal Research
Livzon Pharmaceutical Group Inc.
Mastelli srl, via Bussana Vecchia, Sanremo, Italy
Moorgreen Hospital, Southampton
National Cheng Kung University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
P.D. Hinduja Hospital and Medical Research Centre, Mumbai
People's Liberation Army of China
Postgraduate Institute of Medical Education and Research
Research Associates of New York, LLP
Scandinavian Critical Care Trials Group
South-Eastern Norway Regional Health Authority
Taichung Veterans General Hospital
Universidad Autonoma de Madrid
University of Alabama, Birmingham
University of Alfonso X El Sabio
University of California, San Francisco
Organization Involved with Phase 3 Indications (177)
Asian Institute of Gastroenterology
Asian Institutes of Gastroenterology
Assistance Publique - Hôpitaux de Paris
Canadian Institutes of Health Research (CIHR)
Casa Sollievo della Sofferenza IRCCS
Casa Sollievo della Sofferenza, San Giovanni Rotondo
Centers for Disease Control and Prevention (CDC)
Cristália Produtos Químicos Farmacêuticos Ltda.
European Egyptian Pharmaceutical Industries
European Organisation for Research and Treatment of Cancer
Fundacion Iberoamericana Itaca
German Federal Ministry of Education and Research
Health Research Council, New Zealand
Institut National de la Santé Et de la Recherche Médicale, France
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Lumbini Eye Institute and Hospital
Mashhad University of Medical Sciences
Medical University of South Carolina
National Institute for Communicable Diseases, South Africa
National University of Ireland
Novalead Pharma Private Limited
Nuovo Regina Margherita Hospital
Nutrition Science Partners Limited
Pharmaceutical Research Associates, Inc. (PRA)
Rovi Pharmaceuticals Laboratories
Royal Liverpool & Broadgreen University Hospitals NHS Truts
Sihuan Pharmaceutical Holdings Group Ltd.
Spanish National Health System
Organization Involved with Phase 2 Indications (266)
A2 Healthcare Taiwan Corporation
Academy of Science, Czech Republic
Aleris-Hamlet Hospitals Copenhagen
Azienda Ospedaliera San Giovanni Addolorata
Azienda Ospedaliera Sant'Andrea, Roma
Belarusian State Medical University
Catholic University of Sacred Heart, Rome
Centro Medico Militar, Guatemala
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Cornea Consultants Of Nashville
Crohn's and Colitis Foundation
Energenesis Biomedical Co., Ltd.
Foundation for Clinical Research in IBD
French National Agency for Research on AIDS and Viral Hepatitis
Friedrich Alexander University
Hamilton Health Sciences Corporation
Harrogate & District NHS Foundation Trust
Hemay Pharmaceutical PTY. LTD.
Holy Stone Healthcare Co., Ltd
Hoosier Cancer Research Network
Icahn School of Medicine at Mount Sinai
Istituto Dermopatico dell'Immacolata, Roma
Ivy Institute of Stem Cells Co. Ltd
JP Moulton Charitable Foundation
Katholieke Universiteit Leuven
Klinika Przewodu Pokarmowego Szpital Kliniczny Nr 1 - Lodz - Poland
Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie, Würzburg, Germany
Kolokotrones Family Foundation
Kumasi Centre for Collaborative Research
Kwame Nkrumah University of Science and Technology
Los Angeles Biomedical Research Institute
National Center for Research Resources (NCRR)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institutes of Health (NIH)
Natrogen Therapeutics International, Inc
Queen Elizabeth Hospital NHS Foundation Trust
RegeneRx Biopharmaceuticals, Inc.
Reistone Biopharma Company Limited
Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
Santa Barbara Cottage Hospital
Society for Pediatric Dermatology
Sterna Biologicals GmbH & Co. KG
Technical University of Denmark
Third Military Medical University
Tower Multispecialty Medical Group
Tower Outpatient Surgical Center
Translational Research Informatics Center, Kobe, Hyogo, Japan
Universidad Autónoma de Bucaramanga
Universitaetsklinikum Schleswig-Holstein
University Hospital of North Norway
University of British Columbia
University of California, Los Angeles
University of California, San Diego
University of Erlangen-Nuremberg
University of Illinois at Chicago
University of Naples Frederico II
University of Picardie Jules Verne
University of Roma La Sapienza
University of Rome Tor Vergata
University of Southern California
University of Texas at Houston
Vancouver Island Health Authority
Western Norway Regional Health Authority
Organization Involved with Phase 1 Indications (49)
Organization Involved with Other Experimental Indications (57)
Centre for Infectious Disease Research in Zambia (CIDRZ)
Fengcheng Hospital of Traditional Chinese Medicine
Jawaharlal Institute of Postgraduate Medical Education and Research
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Jiangxi Hospital of Traditional Chinese Medicine
Jiangxi University of Traditional Chinese Medicine
Jiujiang First People's Hospital
Jiujiang Hospital of Traditional Chinese Medicine
National Institute of Nursing Research (NINR)
National Institute on Aging (NIA)
Our Lady of Maryknoll Hospital
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
